Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd.’s Net Profit Dropped 19.6% in First Half of 2023

Zhejiang Wolwo Bio-Pharmaceutical Co.,Ltd. (浙江我武生物科技股份有限公司) (300357.SZ) reported a net profit of 141.7 million yuan in the first half of 2023, down 19.6% year-on-year.

Meanwhile, the company posted 386.3 million yuan in revenue, down 0.7% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 290.9 million yuan in total liabilities, with a liability-to-asset ratio of 11.9%.